- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 607351, 11 pages
Novel Poly(L-lactide-co-ε-caprolactone) Matrices Obtained with the Use of Zr[Acac]4 as Nontoxic Initiator for Long-Term Release of Immunosuppressive Drugs
1Centre of Polymer and Carbon Materials, Polish Academy of Sciences, M. Curie Sklodowskiej 34, 41-819 Zabrze, Poland
2Department of Biopharmacy, School of Pharmacy, Medical University of Silesia, Narcyzow 1, 41-200 Sosnowiec, Poland
3Institut Europeen des Membranes, UMR CNRS 5635, Universite Montpellier 2, Place Eugene Bataillon, 34095 Montpellier, France
4Jan Dlugosz University in Czestochowa, Institute of Chemistry, Environmental Protection and Biotechnology, Armii Krajowej 13, 42-100 Czestochowa, Poland
Received 26 April 2013; Accepted 16 August 2013
Academic Editor: Eder Lilia Romero
Copyright © 2013 Katarzyna Jelonek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- S. Li and M. Vert, “Biodegradable polymers: polyesters,” in Encyclopedia of Controlled Drug Delivery, E. Mathiowitz, Ed., vol. 1, pp. 71–93, John Wiley & Sons, New York, NY, USA, 1999.
- K. van de Velde and P. Kiekens, “Biopolymers: overview of several properties and consequences on their applications,” Polymer Testing, vol. 21, no. 4, pp. 433–442, 2002.
- O. Pillai and R. Panchagnula, “Polymers in drug delivery,” Current Opinion in Chemical Biology, vol. 5, no. 4, pp. 447–451, 2001.
- J. H. An, H. S. Kim, D. J. Chung, D. S. Lee, and S. Kim, “Thermal behaviour of poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) tri-block copolymers,” Journal of Materials Science, vol. 36, no. 3, pp. 715–722, 2001.
- U. Edlund and A. C. Albertsson, “Degradable polymer microspheres for controlled drug delivery,” in Degradable Aliphatic Polyesters, A. C. Albertsson, Ed., pp. 67–113, Springer, Berlin, UK, 2002.
- K. M. Stridsberg, M. Ryner, and A. C. Albertsson, “Controlled ring-opening polymerization: polymers with designed macromolecular architecture,” in Degradable Aliphatic Polyester, A. C. Albertsson, Ed., pp. 40–67, Springer, Berlin, UK, 2002.
- R. Chandra and R. Rustgi, “Biodegradable polymers,” Progress in Polymer Science, vol. 23, no. 7, pp. 1273–1335, 1998.
- H. Sun, L. Mei, C. Song, X. Cui, and P. Wang, “The in vivo degradation, absorption and excretion of PCL-based implant,” Biomaterials, vol. 27, no. 9, pp. 1735–1740, 2006.
- V. R. Sinha, K. Bansal, R. Kaushik, R. Kumria, and A. Trehan, “Poly-ε-caprolactone microspheres and nanospheres: an overview,” International Journal of Pharmaceutics, vol. 278, no. 1, pp. 1–23, 2004.
- Y. Li, K. J. Zhu, J. X. Zhang et al., “In vitro and in vivo studies of cyclosporin A-loaded microspheres based on copolymers of lactide and ε-caprolactone: comparison with conventional PLGA microspheres,” International Journal of Pharmaceutics, vol. 295, no. 1-2, pp. 67–76, 2005.
- M. Carmen Varela, M. Guzmán, J. Molpeceres, M. Del Rosario Aberturas, D. Rodríguez-Puyol, and M. Rodríguez-Puyol, “Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats,” European Journal of Pharmaceutical Sciences, vol. 12, no. 4, pp. 471–478, 2001.
- H. Montazeri Aliabadi, D. R. Brocks, and A. Lavasanifar, “Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution,” Biomaterials, vol. 26, no. 35, pp. 7251–7259, 2005.
- F. Alexis, S. S. Venkatraman, S. K. Rath, and F. Boey, “In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices,” Journal of Controlled Release, vol. 98, no. 1, pp. 67–74, 2004.
- S. O. Marx and A. R. Marks, “Bench to bedside: the development of rapamycin and its application to stent restenosis,” Circulation, vol. 104, no. 8, pp. 852–855, 2001.
- Z. Wei, L. Liu, C. Qu, and M. Qi, “Microstructure analysis and thermal properties of l-lactide/ε-caprolactone copolymers obtained with magnesium octoate,” Polymer, vol. 50, no. 6, pp. 1423–1429, 2009.
- P. F. McDonald, J. G. Lyons, L. M. Geever, and C. L. Higginbotham, “In vitro degradation and drug release from polymer blends based on poly(dl-lactide), poly(l-lactide-glycolide) and poly(ε-caprolactone),” Journal of Materials Science, vol. 45, no. 5, pp. 1284–1292, 2010.
- J. Kasperczyk and M. Bero, “Coordination polymerization of lactides, 2. Microstructure determination of poly[(L,L-lactide)-co-(ε-caprolactone)] with 13C nuclear magnetic resonance spectroscopy,” Macromolecular Chemistry and Physics, vol. 192, pp. 1777–1787, 1991.
- P. Dobrzyński, “Initiation process of L-lactide polymerization carried out with zirconium(IV) acetylacetonate,” Journal of Polymer Science A, vol. 42, no. 8, pp. 1886–1900, 2004.
- B. Buntner, M. Nowak, J. Kasperczyk et al., “The application of microspheres from the copolymers of lactide and ε-caprolactone to the controlled release of steroids,” Journal of Controlled Release, vol. 56, no. 1-3, pp. 159–167, 1998.
- B. Buntner, M. Nowak, M. Bero, P. Dobrzyński, and J. Kasperczyk, “Controlled release of 17β-estradiol from D, L-lactide/ε-caprolactone copolymers,” Journal of Bioactive and Compatible Polymers, vol. 11, no. 2, pp. 110–120, 1996.
- J. Kasperczyk, K. Jelonek, P. Dobrzyñski, and B. Jarz, “The influence of copolymer chain microstructure on cyclosporine a (CyA) and Sirolimus prolonged and sustained release from PLA/TMC and PLA/PCL matrices,” Journal of Controlled Release, vol. 116, no. 2, pp. e5–e6, 2006.
- K. Jelonek, J. Kasperczyk, S. Li, P. Dobrzynski, and B. Jarzabek, “Controlled poly(l-lactide-co-trimethylene carbonate) delivery system of cyclosporine A and rapamycine—the effect of copolymer chain microstructure on drug release rate,” International Journal of Pharmaceutics, vol. 414, no. 1-2, pp. 203–209, 2011.
- J. Kasperczyk, K. Jelonek, K. Gebarowska, P. Dobrzyński, and A. Smola, “Tailoringthe PLATMC chain microstructure for stable cyclosporine A release,” Journal of Controlled Release, vol. 152, pp. e42–e44, 2011.
- R. Gref, P. Quellec, A. Sanchez, P. Calvo, E. Dellacherie, and M. J. Alonso, “Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 51, no. 2, pp. 111–118, 2001.
- N. Katayama, R. Tanaka, Y. Ohno, C. Ueda, T. Houjou, and K. Takada, “Implantable slow release cyclosporin A (CYA) delivery system to thoracic lymph duct,” International Journal of Pharmaceutics, vol. 115, no. 1, pp. 87–93, 1995.
- P. Dobrzynski, S. Li, J. Kasperczyk, M. Bero, F. Gasc, and M. Vert, “Structure-property relationships of copolymers obtained by ring-opening polymerization of glycolide and ε-caprolactone—part 1: synthesis and characterization,” Biomacromolecules, vol. 6, no. 1, pp. 483–488, 2005.
- H. Amini and A. Ahmadiani, “Simple determination of cyclosporine in human whole blood by high-performance liquid chromatography,” Journal of Chromatography B, vol. 795, no. 2, pp. 209–214, 2003.
- K. L. Napoli, “A practical guide to the analysis of sirolimus using high-performance liquid chromatography with ultraviolet detection,” Clinical Therapeutics, vol. 22, pp. B14–B24, 2000.
- J. I. Luengo, D. S. Yamashita, D. Dunnington et al., “Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface,” Chemistry and Biology, vol. 2, no. 7, pp. 471–481, 1995.
- Y. Ran, L. Zhao, Q. Xu, and S. H. Yalkowsky, “Solubilization of cyclosporin A,” AAPS PharmSciTech, vol. 2, no. 1, article 2, 2001.
- S. M. Li, J. L. Espartero, P. Foch, and M. Vert, “Structural characterization and hydrolytic degradation of a Zn metal initiated copolymer of L-lactide and ε-caprolactone,” Journal of Biomaterials Science, Polymer Edition, vol. 8, no. 3, pp. 165–187, 1996.
- J. Kasperczyk and M. Bero, “Coordination polymerization of lactides, 4a. The role of transesterification in the copolymerization of L, L-lactide and e-caprolactone,” Macromolecular Chemistry and Physics, vol. 194, pp. 913–925, 1993.
- T. Urata, K. Arimori, and M. Nakano, “Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres,” Journal of Controlled Release, vol. 58, no. 2, pp. 133–141, 1999.
- M. Chacón, J. Molpeceres, L. Berges, M. Guzmán, and M. R. Aberturas, “Stability and freeze-drying of cyclosporine loaded poly(D,L-lactide-glycolide) carriers,” European Journal of Pharmaceutical Sciences, vol. 8, no. 2, pp. 99–107, 1999.
- J.-W. Lee, J. A. Gardella Jr., W. Hicks Jr., R. Hard, and F. V. Bright, “Analysis of the initial burst of drug release coupled with polymer surface degradation,” Pharmaceutical Research, vol. 20, no. 2, pp. 149–152, 2003.
- C. J. Pan, J. J. Tang, Y. J. Weng, J. Wang, and N. Huang, “Preparation and characterization of rapamycin-loaded PLGA coating stent,” Journal of Materials Science, vol. 18, no. 11, pp. 2193–2198, 2007.
- K. Sternberg, S. Kramer, C. Nischan et al., “In vitro study of drug-eluting stent coatings based on poly(L-lactide) incorporating cyclosporine A - Drug release, polymer degradation and mechanical integrity,” Journal of Materials Science, vol. 18, no. 7, pp. 1423–1432, 2007.
- F. Lallemand, O. Felt-Baeyens, K. Besseghir, F. Behar-Cohen, and R. Gurny, “Cyclosporine A delivery to the eye: a pharmaceutical challenge,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 56, no. 3, pp. 307–318, 2003.
- E. Pamula, P. Dobrzynski, B. Szot et al., “Cytocompatibility of aliphatic polyesters—in vitro study on fibroblasts and macrophages,” Journal of Biomedical Materials Research A, vol. 87, no. 2, pp. 524–535, 2008.
- E. Pamula, L. Bacakova, E. Filova et al., “The influence of pore size on colonization of poly(L-lactide-glycolide) scaffolds with human osteoblast-like MG 63 cells in vitro,” Journal of Materials Science: Materials in Medicine, vol. 19, no. 1, pp. 425–435, 2008.